Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Payables (2016 - 2025)

cbdMD's Payables history spans 10 years, with the latest figure at $880978.0 for Q4 2025.

  • On a quarterly basis, Payables fell 87.11% to $880978.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $880978.0, a 87.11% decrease, with the full-year FY2025 number at $1.2 million, down 81.11% from a year prior.
  • Payables hit $880978.0 in Q4 2025 for cbdMD, down from $1.2 million in the prior quarter.
  • Over the last five years, Payables for YCBD hit a ceiling of $8.0 million in Q1 2025 and a floor of $880978.0 in Q4 2025.
  • Historically, Payables has averaged $3.1 million across 5 years, with a median of $2.7 million in 2022.
  • Biggest five-year swings in Payables: surged 336.13% in 2024 and later plummeted 87.11% in 2025.
  • Tracing YCBD's Payables over 5 years: stood at $3.7 million in 2021, then tumbled by 54.5% to $1.7 million in 2022, then dropped by 7.81% to $1.6 million in 2023, then soared by 336.13% to $6.8 million in 2024, then tumbled by 87.11% to $880978.0 in 2025.
  • Business Quant data shows Payables for YCBD at $880978.0 in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.